Thrashing, its very understandable why anyone would not have confidence in Koos. My own has waned. However, he was able to recruit Christine Ichim to run the research at ENTB. That is an achievement itself and now keeps ENTB alive. The Ichim's are proven entities in the cancer research field combined with the scientific, academic and network they have. Its a matter of time now to prove out the stem cell apprpoach and then be able to market it. ENTB now has direction.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.